Vimarsana
Biggest News Aggregation in the World

Page 40 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Compugen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Compugen Today - Breaking & Trending Today

These are the 10 most beaten-down stocks in Ark Invest's flagship fund as momentum fades for innovative tech bets - Vimarsana News

These are the 10 most beaten-down stocks in Ark Invest's flagship fund as momentum fades for innovative tech bets

Traders work on the floor of the New York Stock Exchange shortly before the closing bell as the market takes a significant dip in New York, U.S.,

Sun: Banks lead downturn at start of week - Vimarsana News

Sun: Banks lead downturn at start of week

The major banks fell heavily today, depressing the main indices, but Elbit Systems maintained its positive momentum.

Tue: Elbit Systems surges but indices slip again - Vimarsana News

Tue: Elbit Systems surges but indices slip again

The main indices posted moderate falls today, with the banks again weak.

Compugen Presents Preliminary Translational Data Demonstrating Immune Activation in the Tumor Microenvironment by COM701 at the TIGIT Therapies Digital Summit - Vimarsana News

Compugen Presents Preliminary Translational Data Demonstrating Immune Activation in the Tumor Microenvironment by COM701 at the TIGIT Therapies Digital Summit

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the...

Compugen Presents Preliminary Translational Data Demonstrating Immune Activation in the Tumor Microenvironment by COM701 at the TIGIT Therapies Digital Summit - Vimarsana News

Compugen Presents Preliminary Translational Data Demonstrating Immune Activation in the Tumor Microenvironment by COM701 at the TIGIT Therapies Digital Summit

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the...